Fortis Healthcare Limited has informed the Exchange about Transcript
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong Q4 and FY26 results with consolidated revenue of INR9,128 crores (up 17.3% YoY) and operating EBITDA margin of 22.8% (vs 20.4% in FY25). Hospital business revenue grew 19.1% to INR7,773 crores with EBITDA margins improving from 20.5% to 22.2%. PAT increased 31.5% to INR1,064 crores. The company added approximately 800 beds through acquisitions (People Tree Bengaluru, Shrimann Jalandhar) and brownfield expansion. Management guided FY27 hospital revenue growth of 15%+ with 150 bps margin improvement and maintains its target of 25% hospital EBITDA margin by FY28. Parent IHH Healthcare has indicated plans to increase its stake to 50% with INR10,000 crore fresh equity infusion for growth capital.
Strong operational performance with clear margin expansion guidance signals confidence in sustaining earnings growth trajectory. The planned INR10,000 crore capital infusion from parent IHH provides funding support for the aggressive bed expansion plan of 1,800 beds over 4 years.